Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- APPLIKATE TECHNOLOGIES, INC.
- Proposal award date
- 2019-09-15
- Contract end date
- 2021-06-30
- UEI
- ZB4HQTBNJ6D4
- Solicitation number
- PA16-452
- Topic code
- 400
Research abstract
Project Summary
Applikate Technologies has developed Clearing Histology with Multiphoton Microscopy (CHiMP), a novel tissue
processing and imaging protocol that provides direct-to-digital images from intact pathology tissue specimens,
such as biopsies, without the need for wax embedding, slicing, or scanning of slides. The application of this
technology to renal diagnosis is expected to improve considerably our ability to render accurate, cost-effective,
and timely diagnoses in patients who suffer from a broad range of kidney problems. It will also expand our ability
to study and understand kidney disorders by providing otherwise inaccessible data which can be analyzed with
emerging computer analysis tools.
The aim of this direct-to-Phase II SBIR proposal is to modify the hardware and software components of CHiMP
for application to kidney biopsies and to validate CHiMPandapos;s non-inferiority for renal diagnosis compared to
standard protocols and its integration into the renal pathology workflow in a clinical setting.
CHiMP has many advantages for general histology, including: Handamp;E-like images familiar to pathologists but with
superior image quality, sub-micron effective thickness, and without artifacts common to slide preparation; non-
destructive imaging that preserves intact tissue for ancillary molecular analysis and immunohistochemistry; rapid
turnaround, with images ready within a few hours of receiving tissue; greatly reduced labor costs; true 3D
prospective; and digitized images for remote consultation and machine vision. NIDDK has identified access to
human kidney biopsies as an important bottle neck for progress in development of precision medicine for acute
and chronic kidney disease. CHiMP directly addresses this by preserving tissue and increasing DNA yields. In
addition, this proposal will extend CHiMPandapos;s imaging to include second harmonic generation from collagen,
thereby enabling evaluation and quantitation of fibrosis, a key factor in renal health and applicable to other
conditions such as liver disease.
The specific aims of this proposal are to: 1) modify the CHiMP microscope and tissue cassettes to enable second
harmonic generation imaging of collagen in kidney biopsies, 2) collect renal biopsy specimens in a clinical setting
and evaluate integration into the clinical workflow and 3) add renal specific visualization features to
Stackstreamer, our 3D visualization software, and demonstrate the utility of CHiMP for diagnosis.
Successful completion of these aims will set the stage for a Phase III transition to regulatory approval and provide
a proven platform for early implementation in select hospitals.Project Narrative
Acute Kidney Injury and Chronic Kidney Disease impose a significant global health burden, but access to
human tissue for development of novel therapies is extremely limited. Applikate Technologies has developed a
powerful tissue processing and imaging technology, Clearing Histology with Multiphoton Microscopy (CHiMP),
that enables pathologist review of precious biopsy samples without consuming or destroying tissue, in contrast
to current approaches, thus retaining more tissue for research. In addition, CHiMP has significant advantages
for clinical application to kidney diseases, including superior image quality, direct visualization of fibrosis, lower
costs, direct-to-digital implementation, and fast, same-day diagnosis. This proposal seeks to adapt CHiMP for
optimized use with kidney tissue and to validate its significant advantages for clinical implementation.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
Research funding history
6 SBIR/STTR records share this UEI (2014–2023). Reported award amounts total $7,807,172. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards